Real-World Effectiveness of Mepolizumab in Patients With Severe Asthma: An Examination of Exacerbations and Costs

Journal of Asthma and Allergy - New Zealand
doi 10.2147/jaa.s236609
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Real-World Safety of Treatment With Mepolizumab and Reslizumab in Patients With Severe Eosinophilic Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Prs55 - Cost-Effectiveness of Mepolizumab in Severe Eosinophilic Asthma Patients in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Mepolizumab Improves Patient Outcomes and Reduces Exacerbations in Severe Asthma Patients With Comorbid Upper Airways Disease

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Cost Effectiveness of Mepolizumab in Adult Asthma Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Mepolizumab Reduces Exacerbations in Patients With Severe Eosinophilic Asthma, Irrespective of Body Weight/Body Mass Index: Meta-Analysis of MENSA and MUSCA

Respiratory Research
PulmonaryRespiratory Medicine
2019English

Relationship of Inhaled Corticosteroid Adherence to Asthma Exacerbations in Patients With Moderate to Severe Asthma

Journal of Allergy and Clinical Immunology: In Practice
AllergyImmunology
2018English

Patients With Severe Eosinophilic Asthma Treated With Mepolizumab: Results From Our Clinical Practice

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Reduced Asthma Exacerbations and Asthma-Related Healthcare Resource Use With Omalizumab From the Real-World PROSPERO Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Asthma Control and Severe Exacerbations in Patients With Moderate or Severe Asthma in Jilin Province, China: A Multicenter Cross-Sectional Survey

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy